A NAPOLEON-2 study to investigate the clinical features of NAL-IRI/FU/LV and explore the predictive and prognostic factors, both retrospectively and prospectively
Latest Information Update: 24 Feb 2023
At a glance
- Drugs Fluorouracil/folinic-acid (Primary) ; Irinotecan (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms NAPOLEON-2
- 21 Jan 2023 Results (n=161) presented at the 2023 Gastrointestinal Cancers Symposium
- 21 Aug 2022 New trial record
- 02 Jul 2022 Results of retrospective part of this trial (n=161 ) presented at the 24th World Congress on Gastrointestinal Cancer